| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 174,926 | 160,340 | 168,123 | 203,668 | | Cost of Revenue | 98,297 | 98,697 | 107,309 | 117,882 | | | Gross Profit | 76,629 | 61,643 | 60,814 | 85,786 | | | Operating Expenses | | Research Development | 16,907 | 16,532 | 16,728 | 16,053 | | Selling General and Administrative | 43,098 | 41,798 | 48,029 | 49,836 | | Non Recurring | 1,696 | 3,110 | 2,338 | 343,062 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,928 | 203 | (6,281) | (323,165) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,834 | 11,294 | (462) | (594) | | Earnings Before Interest And Taxes | 17,762 | 11,497 | (6,743) | (323,759) | | Interest Expense | 6,935 | 5,651 | 5,700 | 7,276 | | Income Before Tax | 10,827 | 5,846 | (12,443) | (331,035) | | Income Tax Expense | (528) | 838 | (557) | (2,259) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 24,214 | 5,008 | (11,886) | (328,776) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,355 | 5,008 | (11,886) | (328,776) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $11,355 | $5,008 | ($11,886) | ($328,776) |
|
0.20% Nasdaq 
0.09 (3.16%) 
Income Statement
